Results 21 to 30 of about 922,822 (266)

Best Practice Statement : Use of Ankle-Foot Orthoses Following Stroke [PDF]

open access: yes, 2009
The development of this Best Practice Statement (BPS) was a collaboration between NHS Quality Improvement Scotland (NHS QIS), National Centre for Prosthetics and Orthotics, University of Strathclyde and a multidisciplinary group of relevant specialists ...
Bowers, R.   +3 more
core   +9 more sources

The Italian NHS: What Lessons to Draw from COVID-19? [PDF]

open access: yesApplied Health Economics and Health Policy, 2020
Garattini, Livio   +2 more
openaire   +4 more sources

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy. [PDF]

open access: yesPLoS ONE, 2016
Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with interferon beta (IFN beta) can develop neutralizing antibodies (NAbs) that reduce treatment efficacy.
Damiano Paolicelli   +11 more
doaj   +1 more source

Changes in private health service utilisation and access to the Italian National Health Service between 2006 and 2019: a cross-sectional comparative study

open access: yesBMJ Open, 2023
Objectives Previous research highlighted that in the early 2000s a significant share of the Italian population used and paid out of pocket for private healthcare services even when they could potentially have received the same treatments from the ...
Maria Pia Fantini   +5 more
doaj   +1 more source

Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy

open access: yesAboutOpen, 2023
Introduction: In classical Hodgkin lymphoma (cHL), the delayed effects of therapies, such as second malignancies and toxicity, and the high relapse rate are potentially associated with an expense for the National Health Service (NHS).
Francesca Fiorentino   +5 more
doaj   +1 more source

Interregional Patient Mobility in the Italian NHS: A Case of Badly-Managed Decentralization; Comment on “Regional Incentives and Patient Cross-Border Mobility: Evidence From the Italian Experience” [PDF]

open access: yesInternational Journal of Health Policy and Management, 2015
The article by Brenna and Spandonaro on interregional mobility for acute hospital care in Italy raises important issues concerning social and territorial equity in a healthcare system.
Stefano Neri
doaj   +1 more source

A Budget impact analysis of pegfilgrastim biosimilar in the treatment of febrile neutropenia in Italy

open access: yesAboutOpen, 2020
Introduction: Granulocyte-colony stimulating factors (G-CSFs) can significantly reduce the risk of febrile neutropenia (FN) among certain patients receiving chemotherapy. FN is associated with significant clinical and nonclinical complications.
Roberto Ravasio   +3 more
doaj   +1 more source

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments

open access: yesJournal of Market Access & Health Policy, 2023
Introduction: Primary immune thrombocytopenia is a rare autoimmune disease characterised by a decreased platelet count resulting in an increased risk of bleeding events and even life-threatening haemorrhages.
Andrea Aiello   +7 more
doaj   +1 more source

Cost-effectiveness analysis with direct-acting antivirals in a cohort of HCV-infected inmates in Italy

open access: yesAboutOpen, 2020
Objective: To evaluate the cost-effectiveness of a strategy based on direct-acting antivirals (DAAs) versus no drug strategy in HCV-infected inmates, from the perspective of the Italian National Health System (iNHS).
Roberto Ravasio   +3 more
doaj   +1 more source

Waiting time information in the Italian NHS: A citizen perspective

open access: yesHealth Policy, 2020
Public involvement in the management and communication of waiting times is known to support initiatives to reduce waiting times, as well as increase fairness and promote transparency and accountability. In order to improve transparency and communication to citizens, Italy recently updated the National Regulatory Plan for Waiting Lists (2019-2021 ...
Sabina De Rosis   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy